Healthcare
With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.
Contact advisorPhen’X Technologies has sold a majority stake to Ciclad
The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.
Learn moreCARSO Group has acquired a majority stake in AQCF Group
CARSO Group, a leading provider of testing services, has acquired a majority stake in AQCF Group, a key player in the field of food safety.
Learn moreInnoxa has sold its eye care activity to Biosynex Group
The private shareholders of Laboratoires Innoxa have sold the company’s eye care activity to Biosynex Group.
Learn moreGérard Meunier
Founder, Formulaction
Read moreStrategic moves and sector-specific trends
QUARTERLY M&A ACTIVITY: From securing growth capital to finding future partners, Oaklins' Q3 deals reflect strategic navigation in dynamic industry landscapes.
Learn moreTalk to our local specialists
Meet our global industry specialists
Michael S. Goldman
Oaklins TM Capital